Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
22 Oct 2025
Curcumin in MASLD and Type 2 Diabetes Treatment
A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.
22 Oct 2025
Cholesterol and Dementia Links in Genetic Meta-Analysis
New genetic research explores whether lowering cholesterol can protect against dementia across major populations.
Cell-based flu vaccines could offer 20% more protection
CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.
22 Oct 2025
IDWeek 2025: HIV Prevention Breakthrough Could Cost $25 Annually
A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.
22 Oct 2025
CHEST 2025: Ensifentrine Boosts Quality of Life in COPD
Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.
22 Oct 2025
Gene-Editing Therapy Boosts Quality of Life in Sickle Cell Disease
Gene-editing therapy exa-cel dramatically improved pain and quality of life in sickle cell disease.
22 Oct 2025
Psoriatic Arthritis Shows Lower Cardiorespiratory Fitness Levels
Cross-sectional testing shows reduced cardiorespiratory fitness in psoriatic arthritis, with disease activity and adiposity linked to lower VO2peak and self-reported activity linked to higher fitness.
7
Mins
22 Oct 2025
Unrepaired TOF with Pulmonary Atresia and MAPCA in Pregnancy
Tetralogy of Fallot (TOF) is one of the most common forms of cyanotic congenital heart disease, characterised by…
22 Oct 2025
RSV Vaccine Cuts Severe Illness in Seniors
RSV vaccine effectiveness in older adults reached high levels against acute respiratory illness in 2023–2024 postlicensure testing.
22 Oct 2025
Cardiovascular Risk Declines with Heated Tobacco Uptake
Heated tobacco use rises as heart hospitalisations fall in Japan, revealing a compelling new tobacco cardiovascular risk trend.
←
1
2
3
…
6
7
8
9
10
11
12
…
1,346
1,347
1,348
→
We’ve noticed you’re accessing
from
North/South America.
View
View